A Phase II/III Trial of Weekly nab-Paclitaxel Plus Gemcitabine or
A Phase II/III Randomized Trial of Two Doses of MK-3475
A phase II, randomized multi-center study of MDX
A Phase II Trial of Perifosine in Patients with Chemo
A phase II study of weekly irinotecan in patients with locally
A Phase II Study of the PARP Inhibitor, Iniparib (BSI-201), in Combination with Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
A Phase II Study of Temozolomide in Patients with Advanced
A phase II study of paclitaxel in advanced
A phase II study of gemcitabine in gallbladder carcinoma
A phase II study of Epirubicin in oxaliplatin
a phase ii randomized trial with captopril in patients who have
A Phase I, open-label, dose-escalation study of continuous once
A phase I, first in human study of FP-1039
A Phase I Trial of Lenalidomide in Patients with Recurrent Primary
A Phase I Study of the Toll-‐like Receptor 5 Agonist, Entolimod, in
A Phase I Study of Paclitaxel, Etoposide, and Cisplatin in Extensive
A phase I study of oral uracil–ftorafur plus folinic acid in combination
A phase I study of high-dose rosuvastatin with standard dose
A phase I study of dexosome immunotherapy in patients with
A Phase I First-in-Human Study of TRC105 (Anti
A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab
